China Medicine Corporation
CHME · OTC
9/30/2010 | 6/30/2010 | 3/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Revenue | $18 | $17 | $11 | $20 |
| % Growth | 2.1% | 62.6% | -48.3% | – |
| Cost of Goods Sold | $12 | $11 | $7 | $14 |
| Gross Profit | $6 | $6 | $3 | $7 |
| % Margin | 33.1% | 35.5% | 30.7% | 33.5% |
| R&D Expenses | $1 | $0 | $0 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $2 | $2 | $3 |
| Operating Income | $2 | $4 | $1 | $4 |
| % Margin | 14.2% | 22% | 11.8% | 20.5% |
| Other Income/Exp. Net | $1 | $1 | $1 | -$5 |
| Pre-Tax Income | $3 | $5 | $2 | -$1 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | $2 | $4 | $2 | -$2 |
| % Margin | 12.7% | 23.9% | 17% | -10.2% |
| EPS | 0.1 | 0.19 | -0.23 | -0.14 |
| % Growth | -47.4% | 182.6% | -64.3% | – |
| EPS Diluted | 0.06 | 0.1 | -0.23 | -0.14 |
| Weighted Avg Shares Out | 22 | 22 | 19 | 15 |
| Weighted Avg Shares Out Dil | 40 | 40 | 19 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $3 | $4 | $2 | $5 |
| % Margin | 16.6% | 24.8% | 16.2% | 22.2% |